FindTrial
Sign In

A study of antimicrobial agents used and antibiotics sensitivity pattern in community acquired pneumonia at a tertiary centre.

Observational study of profile of antimicrobial agents and antibiotics sensitivity pattern in community acquired pneumonia at a tertiary centre.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/011788
Enrollment
150
Registered
2018-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Community Acquired Pneumonia

Interventions

Control Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All the patient of both sex and age above 18 years. 2.Patients given written inform consent

Exclusion criteria

Exclusion criteria: 1.Patients aged below 18 years. 2.Patients already taking antimicrobial agents for more than 7 days. 3.Ventilator associated pneumonia. 4.Patient with Immunocompromised state, Lung cancers and Tuberculosis.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures, will be use of most frequently prescribed antibacterial agents as empirical and definitive therapy. The Antibiotics Consumption Index were calculated and compared between the therapies.Timepoint: 14 days—

Secondary

MeasureTime frame
Measured the Antibiotics Consumption Index(ACI)of empirical and definitive therapy for community acquired pneumonia.Timepoint: 7 days—

Countries

India

Contacts

Public ContactDr Mamta Yadav

Sarojini Naidu Medical College, Agra

drashwininigam@gmail.com9760492173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026